Literature DB >> 7117286

The efficacy of growth hormone in different types of growth failure. An analysis of 101 cases.

H L Lenko, S Leisti, J Perheentupa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7117286     DOI: 10.1007/bf00441210

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  48 in total

Review 1.  Growth hormone deficiency in childhood. Evaluation of diagnostic procedures.

Authors:  E E Joss
Journal:  Monogr Paediatr       Date:  1975

2.  Two-hour adrenocorticotropic hormone test: accuracy in the evaluation of the hypothalamic-pituitary-adrenocortical axis.

Authors:  S Leisti; J Perheentupa
Journal:  Pediatr Res       Date:  1978-04       Impact factor: 3.756

3.  Mulibrey nanism, an autosomal recessive syndrome with pericardial constriction.

Authors:  J Perheentupa; S Autio; S Leisti; C Raitta; L Tuuteri
Journal:  Lancet       Date:  1973-08-18       Impact factor: 79.321

4.  Acute and long-term responsiveness to growth hormone in children with short stature.

Authors:  J A Grunt; A R Enriquez
Journal:  Pediatr Res       Date:  1972-08       Impact factor: 3.756

5.  Height, weight, and the assessment of obesity in children.

Authors:  E M Newens; H Goldstein
Journal:  Br J Prev Soc Med       Date:  1972-02

6.  Growth in Turner's syndrome: spontaneous and fluoxymesterone stimulated.

Authors:  H L Lenko; J Perheentupa; A Söderholm
Journal:  Acta Paediatr Scand Suppl       Date:  1979

7.  Experience with human growth hormone in Great Britain: the report of the MRC Working Party.

Authors:  R D Milner; T Russell-Fraser; C G Brook; P M Cotes; J W Farquhar; J M Parkin; M A Preece; G J Snodgrass; A S Mason; J M Tanner; F P Vince
Journal:  Clin Endocrinol (Oxf)       Date:  1979-07       Impact factor: 3.478

8.  Growth hormone deficiency and growth hormone therapy in Ullrich-Turner-syndrome.

Authors:  O Butenandt
Journal:  Klin Wochenschr       Date:  1980-01-15

9.  Interrelation of the therapeutic effects of growth hormone and testosterone on growth in hypopituitarism.

Authors:  A Aynsley-Green; M Zachmann; A Prader
Journal:  J Pediatr       Date:  1976-12       Impact factor: 4.406

10.  Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.

Authors:  K W Kastrup; H Andersen; P C Eskildsen; B B Jacobsen; S Krabbe; K E Petersen
Journal:  Acta Paediatr Scand Suppl       Date:  1979
View more
  7 in total

1.  Assignment of the mulibrey nanism gene to 17q by linkage and linkage-disequilibrium analysis.

Authors:  K Avela; M Lipsanen-Nyman; J Perheentupa; C Wallgren-Pettersson; S Marchand; S Fauré; P Sistonen; A de la Chapelle; A E Lehesjoki
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

2.  Who should get growth hormone?

Authors:  R D Milner
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

3.  Antibody deficiency and isolated growth hormone deficiency in a girl with Mulibrey nanism.

Authors:  A Haraldsson; C J van der Burgt; C M Weemaes; B Otten; J A Bakkeren; G B Stoelinga
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

4.  When are we diagnosing growth hormone deficiency?

Authors:  S M Herber; R D Milner
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

Review 5.  Growth hormone treatment in children: review of safety and efficacy.

Authors:  Mark Harris; Paul L Hofman; Wayne S Cutfield
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

6.  The Northern Ireland experience of growth hormone therapy for short stature.

Authors:  H M Whitehead; D R Hadden; D J Carson
Journal:  Ulster Med J       Date:  1989-10

Review 7.  Human Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future.

Authors:  Evan Graber; Edward O Reiter; Alan D Rogol
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-05       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.